• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者微侵犯的影响因素:可能应用于临床肿瘤体积的定义。

Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume.

机构信息

Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):467-76. doi: 10.1016/j.ijrobp.2009.01.057. Epub 2009 May 4.

DOI:10.1016/j.ijrobp.2009.01.057
PMID:19406586
Abstract

PURPOSE

To evaluate the degree of invasion of hepatocellular carcinoma (HCC) microscopically that will provide a potential application for gross tumor volume to clinical tumor volume (GTV-to-CTV) expansion.

METHODS AND MATERIALS

From January 2002 to January 2006, 149 HCC patients were selected from those who had undergone surgical resection. Pathology slides and clinical data of all patients were reviewed, including platelet counts, serum alpha-fetoprotein (AFP) levels, degree of liver cirrhosis, tumor size, capsular status, portal vein invasion, TNM stage, and histologic tumor grade. The distance between the tumor margin (or fibrous capsule) and the invasive lesions was measured by senior pathologists.

RESULTS

Of these 149 patients, 79 (53.0%) patients presented with tumor microinvasion between 0.5 and 4 mm. This degree of microinvasion was inversely correlated with lower platelet counts and positively correlated with higher AFP levels, larger tumor sizes, portal vein invasion, and advanced TNM stage. Microinvasion distances less than or equal to 2 mm were found in 96.1% of patients (74/77) with tumor dimensions less than or equal to 5 cm and in 94.5% of patients (85/90) with AFP levels less than 400 microg/l.

CONCLUSIONS

Based on our study findings, GTV-to-CTV expansions of 4 mm for HCC are required to conceal the gross tumor and any microscopic disease with 100% accuracy. Tumor size and AFP levels are the simplest indicators for determining the GTV-to-CTV distance for HCC.

摘要

目的

评估肝癌(HCC)的微观侵袭程度,为肿瘤总体积到临床肿瘤体积(GTV-to-CTV)的扩展提供潜在的应用。

方法和材料

从 2002 年 1 月至 2006 年 1 月,从接受手术切除的患者中选择了 149 例 HCC 患者。回顾所有患者的病理切片和临床资料,包括血小板计数、血清甲胎蛋白(AFP)水平、肝硬化程度、肿瘤大小、包膜状态、门静脉侵犯、TNM 分期和组织学肿瘤分级。由资深病理学家测量肿瘤边缘(或纤维囊)与侵袭性病变之间的距离。

结果

在这 149 例患者中,79 例(53.0%)患者存在 0.5 至 4 毫米的肿瘤微侵袭。这种程度的微侵袭与较低的血小板计数呈负相关,与较高的 AFP 水平、较大的肿瘤大小、门静脉侵犯和较晚期的 TNM 分期呈正相关。在肿瘤直径小于或等于 5 厘米的 77 例患者(96.1%)和 AFP 水平小于 400μg/l 的 90 例患者(94.5%)中,发现微侵袭距离小于或等于 2 毫米。

结论

根据我们的研究结果,HCC 的 GTV-to-CTV 扩展需要以 100%的准确性掩盖大体肿瘤和任何微观疾病,肿瘤大小和 AFP 水平是确定 HCC GTV-to-CTV 距离的最简单指标。

相似文献

1
Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume.肝细胞癌患者微侵犯的影响因素:可能应用于临床肿瘤体积的定义。
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):467-76. doi: 10.1016/j.ijrobp.2009.01.057. Epub 2009 May 4.
2
Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.肝细胞癌患者血清脯氨酰肽酶与甲胎蛋白水平之间的相关性评估。
World J Gastroenterol. 2015 Jun 14;21(22):6999-7007. doi: 10.3748/wjg.v21.i22.6999.
3
Microinvasion in hepatocellular carcinoma: predictive factor and application for definition of clinical target volume for radiotherapy.肝细胞癌的微侵袭:预测因素及其在放射治疗临床靶区定义中的应用。
World J Surg Oncol. 2024 May 8;22(1):125. doi: 10.1186/s12957-024-03399-1.
4
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的晚期肝细胞癌肝切除术后的生存率
World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.
5
Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume.肝内胆管细胞癌微侵犯的影响因素:定义临床靶区的可能系统。
Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1427-36. doi: 10.1016/j.ijrobp.2009.09.069. Epub 2010 Apr 6.
6
Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.肝癌的化疗栓塞:362 例患者队列中肿瘤反应和生存的多因素分析预测因素。
J Vasc Interv Radiol. 2011 Jul;22(7):917-23. doi: 10.1016/j.jvir.2011.03.005. Epub 2011 May 14.
7
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.慢性肝炎、肝硬化和肝细胞癌患者的去γ-羧基凝血酶原、甲胎蛋白和甲胎蛋白-L3
J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.
8
[Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].α-甲胎蛋白在肝细胞癌诊断中的应用
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):440-3.
9
Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma.肝细胞癌患者门静脉侵犯的预后因素
J Gastroenterol. 2006 Dec;41(12):1214-9. doi: 10.1007/s00535-006-1950-7. Epub 2007 Feb 6.
10
Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.豆凝集素反应性甲胎蛋白与肝细胞癌病理特征的关系
Liver Int. 2005 Aug;25(4):848-53. doi: 10.1111/j.1478-3231.2005.01111.x.

引用本文的文献

1
Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴门静脉癌栓的晚期肝细胞癌的治疗策略
Ewha Med J. 2025 Jan;48(1):e4. doi: 10.12771/emj.2025.e4. Epub 2025 Jan 31.
2
Microinvasion in hepatocellular carcinoma: predictive factor and application for definition of clinical target volume for radiotherapy.肝细胞癌的微侵袭:预测因素及其在放射治疗临床靶区定义中的应用。
World J Surg Oncol. 2024 May 8;22(1):125. doi: 10.1186/s12957-024-03399-1.
3
Influence of different region of interest sizes on CT-based radiomics model for microvascular invasion prediction in hepatocellular carcinoma.
不同感兴趣区大小对基于 CT 的肝癌微血管侵犯预测放射组学模型的影响。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Aug 28;47(8):1049-1057. doi: 10.11817/j.issn.1672-7347.2022.220027.
4
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition).中国肝细胞癌合并门静脉癌栓诊断和治疗多学科专家共识(2021年版)
Liver Cancer. 2022 Mar 17;11(4):315-328. doi: 10.1159/000523997. eCollection 2022 Jul.
5
A preliminary investigation of re-evaluating the irradiation dose in hepatocellular carcinoma radiotherapy applying 4D CT and deformable registration.应用4D CT和可变形配准重新评估肝细胞癌放疗中照射剂量的初步研究。
J Appl Clin Med Phys. 2021 Feb;22(2):13-20. doi: 10.1002/acm2.13111. Epub 2021 Jan 15.
6
Clinical and Pathological Study of Tumor Border Invasion-Is Narrow Resection Margin Acceptable in Hepatoblastoma Surgery?肝母细胞瘤手术中肿瘤边界侵犯的临床与病理研究——窄切缘是否可接受?
Front Med (Lausanne). 2020 Mar 4;7:59. doi: 10.3389/fmed.2020.00059. eCollection 2020.
7
Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition).《肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2018年版)》
Liver Cancer. 2020 Jan;9(1):28-40. doi: 10.1159/000503685. Epub 2019 Nov 6.
8
The tumor diameter cut-off for predicting microscopic intrahepatic metastasis of hepatocellular carcinoma patients without treatment history differs from that of hepatocellular carcinoma patients with a treatment history.肿瘤直径截断值对于预测无治疗史的肝细胞癌患者的微小肝内转移与预测有治疗史的肝细胞癌患者的微小肝内转移不同。
Clin Transl Oncol. 2020 Mar;22(3):319-329. doi: 10.1007/s12094-019-02120-z. Epub 2019 Apr 30.
9
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).《中国原发性肝癌诊疗规范(2017年版)》
Liver Cancer. 2018 Sep;7(3):235-260. doi: 10.1159/000488035. Epub 2018 Jun 14.
10
Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting.第七届亚太原发性肝癌专家会议关于小尺寸肝细胞癌立体定向体部放射治疗的共识
Liver Cancer. 2017 Nov;6(4):264-274. doi: 10.1159/000475768. Epub 2017 Aug 30.